Phase 3 Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a solid tumour (such as breast, lung, stomach, cervical, uterine, ovarian, pancreatic cancer, or melanoma, among others), confirmed by a tissue or cell sample
- People aged 18 or older
- People who are planned to receive a type of chemotherapy called taxane-based treatment (such as paclitaxel, nab-paclitaxel, or docetaxel, alone or combined with other medicines) either before or after surgery for early-stage cancer, or people with advanced cancer who have not yet had chemotherapy
- People with a life expectancy of at least 3 months
- People who are reasonably active and able to care for themselves, as measured by a standard medical scale (confirm with trial site)
- People whose heart, liver, kidneys, and bone marrow are functioning well enough to safely receive chemotherapy
- People who are willing and able to sign a consent form and follow the study procedures
Who may not be able to join:
- People whose major organs are not functioning well enough to safely handle standard doses of chemotherapy
- People who already have, or have previously had, nerve damage in their hands or feet (a condition called peripheral neuropathy)
- People with certain skin conditions on their hands or feet, or an active skin infection, that could make it difficult to assess nerve-related symptoms
- People who have recently taken medicines that may reduce nerve pain or related symptoms (confirm with trial site for specific medicines)
- People who have difficulty swallowing, a bowel obstruction, or any other condition that could affect how the body absorbs medication
- People who are known to have an allergy or sensitivity to a substance called mecobalamin
- People who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 869716230893
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cumulative incidence of grade ≥2 chemotherapy induced peripheral neuropathy (CIPN)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.